Overall, these results demonstrated that CMFPs could have better therapeutic effects on zebrafish colitis via activating the MyD88/NF-κB inflammatory signaling pathway, and thereby regulating inflammatory cytokines. This evidence concerns the gene MYD88 and colitis.